BioMarin Pharmaceutical Price Target Increased to $125.00 by Analysts at … – Dakota Financial News

BioMarin Pharmaceutical Price Target Increased to $125.00 by Analysts at
Dakota Financial News
BioMarin Pharmaceutical Inc. logo BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target increased by JPMorgan Chase & Co. from $120.00 to $125.00 in a research report sent to investors on Friday morning. The firm currently has an overweight …
BioMarin Pharmaceutical Receives $117.00 Consensus Price Target from sleekmoney
Hot Issues on BioMarin Pharmaceutical Inc. Earnings Conference CallMotley Fool
BioMarin Pharmaceutical (BMRN) Earnings Report: Q1 2015 Conference Call TheStreet.com
Seeking Alpha -The Legacy -Mideast Time
all 27 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd